CN1733081A - Chinese medicine preparation for nourishing blood and tranquilizing mind and its preparation process - Google Patents
Chinese medicine preparation for nourishing blood and tranquilizing mind and its preparation process Download PDFInfo
- Publication number
- CN1733081A CN1733081A CN 200510003181 CN200510003181A CN1733081A CN 1733081 A CN1733081 A CN 1733081A CN 200510003181 CN200510003181 CN 200510003181 CN 200510003181 A CN200510003181 A CN 200510003181A CN 1733081 A CN1733081 A CN 1733081A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- preparation
- add
- radix rehmanniae
- reduced pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims description 57
- 238000002360 preparation method Methods 0.000 title claims description 57
- 239000008280 blood Substances 0.000 title claims description 20
- 210000004369 blood Anatomy 0.000 title claims description 20
- 230000002936 tranquilizing effect Effects 0.000 title description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 118
- 238000000034 method Methods 0.000 claims abstract description 56
- 239000002775 capsule Substances 0.000 claims abstract description 44
- 238000000605 extraction Methods 0.000 claims abstract description 9
- 244000307697 Agrimonia eupatoria Species 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims description 31
- 235000008504 concentrate Nutrition 0.000 claims description 30
- 239000012141 concentrate Substances 0.000 claims description 30
- 239000000463 material Substances 0.000 claims description 29
- 238000003756 stirring Methods 0.000 claims description 26
- 239000006228 supernatant Substances 0.000 claims description 26
- 239000000706 filtrate Substances 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000013543 active substance Substances 0.000 claims description 20
- 239000008187 granular material Substances 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 11
- 239000012567 medical material Substances 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 7
- 238000007560 sedimentation technique Methods 0.000 claims description 7
- 239000006188 syrup Substances 0.000 claims description 7
- 235000020357 syrup Nutrition 0.000 claims description 7
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- -1 sublimed preparation Substances 0.000 claims description 3
- 235000016993 Agrimonia Nutrition 0.000 claims description 2
- 235000011438 Albizia odoratissima Nutrition 0.000 claims description 2
- 244000286838 Eclipta prostrata Species 0.000 claims description 2
- 239000003405 delayed action preparation Substances 0.000 claims description 2
- 239000006196 drop Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 240000005482 Albizia procera Species 0.000 claims 1
- 239000012535 impurity Substances 0.000 abstract description 8
- 241000405414 Rehmannia Species 0.000 abstract 2
- 240000007185 Albizia julibrissin Species 0.000 abstract 1
- 235000011468 Albizia julibrissin Nutrition 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000000125 common agrimony Nutrition 0.000 abstract 1
- 210000003462 vein Anatomy 0.000 abstract 1
- 239000001095 magnesium carbonate Substances 0.000 description 29
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 29
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 29
- 239000000203 mixture Substances 0.000 description 26
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 25
- 239000000741 silica gel Substances 0.000 description 25
- 229910002027 silica gel Inorganic materials 0.000 description 25
- 229920001353 Dextrin Polymers 0.000 description 23
- 239000004375 Dextrin Substances 0.000 description 23
- 235000019425 dextrin Nutrition 0.000 description 23
- 230000000694 effects Effects 0.000 description 22
- 239000002131 composite material Substances 0.000 description 20
- 230000007812 deficiency Effects 0.000 description 17
- 239000000796 flavoring agent Substances 0.000 description 16
- 235000019634 flavors Nutrition 0.000 description 14
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 11
- 238000005520 cutting process Methods 0.000 description 11
- 206010022437 insomnia Diseases 0.000 description 11
- 238000001694 spray drying Methods 0.000 description 11
- 238000002156 mixing Methods 0.000 description 10
- 239000003826 tablet Substances 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 150000001720 carbohydrates Chemical class 0.000 description 7
- 230000002950 deficient Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 235000018553 tannin Nutrition 0.000 description 6
- 239000001648 tannin Substances 0.000 description 6
- 229920001864 tannin Polymers 0.000 description 6
- 230000002618 waking effect Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 208000013403 hyperactivity Diseases 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- QIIDATRCGITYRZ-UHFFFAOYSA-N Catalpol Natural products OCC1OC(OC2OC=CC3C(O)C(=C(CO)C23)O)C(O)C(O)C1O QIIDATRCGITYRZ-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 description 4
- UXSACQOOWZMGSE-UHFFFAOYSA-N catalposide Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(OC(=O)C=3C=CC(O)=CC=3)C2C=CO1 UXSACQOOWZMGSE-UHFFFAOYSA-N 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 229940032147 starch Drugs 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- 229920000881 Modified starch Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 235000019426 modified starch Nutrition 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000345998 Calamus manan Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- ZUKLFFYDSALIQW-MSUKCBDUSA-N Iridoid glycoside Chemical compound [H][C@]12CC[C@H](C(O)=O)[C@@]1([H])[C@H](OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)OC=C2 ZUKLFFYDSALIQW-MSUKCBDUSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000004368 Modified starch Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 229930182482 anthraquinone glycoside Natural products 0.000 description 2
- 229940098421 anthraquinone glycoside Drugs 0.000 description 2
- 150000008139 anthraquinone glycosides Chemical class 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 229930182489 iridoid glycoside Natural products 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 206010027175 memory impairment Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 235000012950 rattan cane Nutrition 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000004622 sleep time Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 240000000559 Albizia odoratissima Species 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 102100032352 Leukemia inhibitory factor Human genes 0.000 description 1
- 108090000581 Leukemia inhibitory factor Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 240000006028 Sambucus nigra Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229960001305 cysteine hydrochloride Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 238000011169 microbiological contamination Methods 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 150000003376 silicon Chemical class 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 229940080313 sodium starch Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- ZAVXXBAIPSQJGS-UHFFFAOYSA-B tetracalcium;tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O.[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O.[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O ZAVXXBAIPSQJGS-UHFFFAOYSA-B 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a Chinese medicinal capsule for blood-nourishing and tranquilization, and its preparing process, comprising the extraction of active ingredients from multiflower knotweed root, spatholobus stem, prepared rehmannia root, dried rehmannia root, mimosa-tree bark, herba ecliptae, hairy vein agrimony, then removing impurity with ethanol of different concentration.
Description
Technical field:
The present invention relates to a kind of Chinese medicine preparation with nourishing blood to tranquillize the mind effect, particularly capsule preparations and preparation method thereof.
Technical background:
The nourishing blood to tranquillize the mind preparation be by Caulis Polygoni Multiflori, Caulis Spatholobi, Radix Rehmanniae Preparata, Radix Rehmanniae, Cortex Albiziae, Herba Ecliptae, Herba Agrimoniae altogether seven flavor medicine be prepared into have a nourishing YIN and benefiting blood, the compound Chinese medicinal preparation of mind tranquilizing and the heart calming effect, to upper respiratory tract infection, tracheitis, pneumonia, diseases such as cough have definite curative effect, be used for tired mind, insomnia forgetfulness, the bedroom dreaminess of crouching, the soreness of waist of suffering from a deficiency of the kidney, the dizzy weak disease of waiting.The nourishing blood to tranquillize the mind preparation that has gone on the market at present mainly contains pill, syrup, tablet.These preparations, what the extraction process of its Chinese medicine adopted all is the decocting cooking method, concrete grammar be part or all of medical material through decocting, concentrate extractum, or add medicated powder again and make pill, syrup or tablet.
Because Radix Rehmanniae Preparata, Radix Rehmanniae contain a large amount of saccharides and phlegmatic temperament composition in the prescription, Cortex Albiziae, Herba Ecliptae etc. then contain tannin, these medical materials are through after the water boiling and extraction, impurity component wherein can both be dissolved in the medicine of a warm nature liquid that solvent is a water, saccharide, phlegmatic temperament and tannin still can be passed through during the heat filter, concentrate at last and obtain more heavy-gravity extractum, these impurity are just stayed in the extractum.The existence of these impurity can cause some side effect, makes product not reach higher quality.For syrup, because the cause of saccharide and tannin at its lay up period, certainly leads to precipitation or mycete; For pill or tablet, and saccharide, mucilaginous existence, the both very easily aborning easily microbiological contamination and molten loosing transfinite, thereby influence the quality of the pharmaceutical preparations.
The present invention is directed to the defective of traditional handicraft, improved technology, proposing with water is solvent extraction medical material effective ingredient, and the reuse Different concentrations of alcohol makes contamination precipitation and the method for removing.Played the effect of remove impurity.In addition, through comparative study, the present invention finds, adopts capsule formulation to have more advantage to preparation of the present invention, particularly can cover the bad smell of medical material, and patients such as convenient for children, old man take.Can improve medicine stability and not be heated cold influence.Non-hygroscopic moisture should be controlled; The bioavailability height, disintegrate is fast, takes the general 3-10min in back and discharges medicine with regard to disintegrate, can regularly discharge medicine, and in mixing incapsulated, 30min promptly reached peak concentration in the blood, and lasting curative effect reaches 11h.
Summary of the invention:
The invention provides a kind of nourishing blood to tranquillize the mind Chinese medicine preparation.
Nourishing blood to tranquillize the mind Chinese medicine preparation of the present invention, its prescription is composed as follows:
Caulis Polygoni Multiflori 30-180 part, Caulis Spatholobi 30-180 part, Radix Rehmanniae Preparata 30-180 part, Radix Rehmanniae 30-180 part, Cortex Albiziae 30-180 part, Herba Ecliptae 30-180 part, Herba Agrimoniae 120-200 part.
Preferred prescription is composed as follows:
100 parts of Caulis Polygoni Multiflori, 100 parts of Caulis Spatholobis, 100 parts of Radix Rehmanniae Preparata, 100 parts of Radix Rehmanniae, 100 parts of Cortex Albiziaes, 140 parts of Herba Ecliptaes, 160 parts of Herba Agrimoniaes.
In more than forming, the weight of medicine is calculated with crude drug, and this prescription composition can be made into 1000 doses of pharmaceutical preparatioies.Described 1000 doses of fingers, the final drug preparation of making, as make 1000 of capsule preparations, 1000 in tablet, granule 1000 grams, oral liquid 1000ml etc., also can make big packing as granule, as the 100-500 bag, specifically can be 100 bags, 125 bags, 200 bags, 250 bags, 500 bags etc., every bag can be used as taking dose 1-2 time.
More than form, can be made into the preparation of 50-1000 taking dose,, make 1000, make 1000 of capsules as tablet, each taking dose can be the 1-20 sheet/or, can take 50-1000 time altogether.As granule, make 125 bags, take the 1-2 bag at every turn, can take 62.5-125 time altogether.
More than form to be by weight as proportioning, when producing, can increase or reduce according to corresponding proportion, as large-scale production can be unit with the kilogram, or be unit with the ton, small-scale production can be unit with the milligram also, weight can increase or reduce, but the constant rate of the raw medicinal herbs weight proportion between each composition.
The ratio of above weight proportion obtains through science screening, for especial patient, and as serious symptom or light disease, fat or modest patient, the proportioning of the amount of can corresponding adjustment forming increases or reduces being no more than 100%, and drug effect is constant.
Raw material of Chinese medicine, especially ministerial drug and adjuvant drug in more than forming also can be replaced by the suitable Chinese medicine with identical property of medicine, and its drug effect of the Chinese medicine preparation after the replacement is constant.
Chinese medicine preparation of the present invention is to process through extraction or other modes by the raw material of Chinese medicine that above-mentioned prescription is formed, and makes pharmaceutically active substance, subsequently, with this material is raw material, adds the medicine acceptable carrier when needing, and makes according to the routine techniques of galenic pharmacy.Described active substance can obtain by extracting raw material of Chinese medicine respectively, also can obtain by the co-extracted raw material of Chinese medicine.
The present invention also provides the preparation method of above-described pharmaceutically active substance, the present invention is directed to effective ingredient and impurity such as all water-soluble characteristics of polysaccharide, phlegmatic temperament and tannin in the prior art, proposes to prepare described pharmaceutically active substance with decoction and alcohol sedimentation technique.
Preparation method of the present invention is according to the different dissolubilities of various compositions in each medical material in water and ethanol.By water and Different concentrations of alcohol alternate treatment, keep iridoid glycoside, the dissociated anthraquinone glycoside, effective ingredient such as alkaloid, make contamination precipitation, remove by filter one by one then, i.e. elder generation's employing ethanol content is that the alcoholic solution of 50-60% is removed gelatinized starch, phlegmatic temperament and saccharide, and the alcoholic solution of reuse more than 75% removed tannin and all the other most of impurity.Caulis Polygoni Multiflori contains anthraquinone analog compound, mainly contain chrysophanol and emodin, the effective ingredient of Radix Rehmanniae is that iridoid glycosideses such as catalpol are water-soluble, so use earlier water-boiling method, increase along with decocting time and temperature, the continuous stripping of saccharide, phlegmatic temperament and tannin, easily stick with paste during decoction in other medical material surfaces, stop up the cell wall passage, hinder the stripping of other effective ingredient, thus the present invention with catalpol content as index, to Radix Rehmanniae Preparata, Radix Rehmanniae, the optimum process condition when seven flavor medicine materials such as Caulis Polygoni Multiflori decoct is jointly selected.
The preparation method of preferred active substance of the present invention is as follows: above seven flavor medicine material, cut into chunks, and decoct with water, collecting decoction filters concentrate under reduced pressure at low temperature.Add Different concentrations of alcohol at twice, fully stir, leave standstill, divide and get supernatant, sucking filtration merges, and concentrate under reduced pressure at low temperature gets clear paste, active substance promptly of the present invention.
The preparation method of most preferred active substance of the present invention is as follows: seven flavor medicine materials such as Caulis Polygoni Multiflori, Radix Rehmanniae Preparata, Radix Rehmanniae, the section of being ground into or piece, add 6-10 times of water, soak after 0.5-5 hour and decoct 1-3 time, each 2 hours, collecting decoction filters, and gets the clear paste that filtrate concentrate under reduced pressure at low temperature to relative density is 1.05～1.15 (50 ℃).Add the ethanol of 50-60% in the time of 40 ℃, stir, make medicinal liquid contain the alcohol amount and reach 50-60%, under 5-10 ℃, left standstill 6-8 hour.Divide and get supernatant, the ethanol that adds 75-90% again, stir, make medicinal liquid contain the alcohol amount and reach 75-90%, under 5-10 ℃, left standstill the siphon supernatant 8-12 hour, lower floor's magma is sucking filtration slowly again, merging filtrate, concentrate under reduced pressure at low temperature to relative density are the clear paste of 1.10～1.20 (50 ℃), active substance promptly of the present invention.
These active substances can be the materials of extractum form, can be that dry extract also can be a fluid extract, make different concentration according to the different needs decision of preparation.
Pharmaceutically active substance in the Chinese medicine preparation of the present invention, its shared percentage by weight in preparation can be 0.1-99.9%, all the other are the medicine acceptable carrier.Pharmaceutical preparation of the present invention exists with unit dosage form, and described unit dosage form is meant the unit of preparation, as every of tablet, capsular every capsules, every of injection etc., in the unit dose, the amount that contains active substance is 5-800mg, preferably 20-500mg.
Chinese medicine preparation of the present invention can be any pharmaceutically useful dosage form, these dosage forms comprise: tablet, capsule, oral liquid, syrup, granule, pill, powder, unguentum, sublimed preparation, injection, suppository, cream, spray, drop pill, patch, slow releasing preparation, controlled release preparation, preferably capsule.
Pharmaceutical preparation of the present invention, the preparation of its oral administration can contain excipient commonly used, such as binding agent, filler, diluent, tablet agent, lubricant, disintegrating agent, coloring agent, flavoring agent and wetting agent, can carry out coating to tablet in case of necessity.
The filler that is suitable for comprises cellulose, mannitol, lactose and other similar filler.Suitable disintegrating agent comprises starch, polyvinylpyrrolidone and starch derivatives, for example sodium starch glycollate.Suitable lubricant, for example magnesium stearate.The acceptable wetting agent of appropriate drug comprises sodium lauryl sulphate.
Can fill by mixing, the method that tabletting etc. are commonly used prepares solid oral composition.Mix repeatedly active substance is distributed in those compositionss of a large amount of filleies of whole use.
The form of oral liquid for example can be aqueous or oily suspensions, solution, Emulsion, syrup or elixir, perhaps can be a kind of available water before use or other suitable composite dry products of carrier.This liquid preparation can contain conventional additive, such as suspending agent, for example sorbitol, syrup, methylcellulose, gelatin, hydroxyethyl-cellulose, carboxymethyl cellulose, aluminium stearate gel or hydrogenation edible fat, emulsifying agent, for example lecithin, anhydro sorbitol monooleate or arabic gum; Non-aqueous carrier (they can comprise edible oil), for example almond oil, fractionated coconut oil, such as oily ester, propylene glycol or the ethanol of the ester of glycerol; Antiseptic, for example para hydroxybenzene methyl ester or propyl p-hydroxybenzoate or sorbic acid, and if desired, can contain conventional flavouring agent or coloring agent.
For injection, the liquid unit dosage forms of preparation contains active substance of the present invention and sterile carrier.According to carrier and concentration, this chemical compound can be suspended or dissolving.The preparation of solution is normally by being dissolved in active substance in a kind of carrier filter-sterilized before it is packed into a kind of suitable bottle or ampoule, sealing then.For example a kind of local anesthetic of adjuvant, antiseptic and buffer agent also can be dissolved in this carrier.In order to improve its stability, can be after the bottle of packing into that this compositions is freezing, and under vacuum, water is removed.
Pharmaceutical preparation of the present invention, when being prepared into medicament, optionally add suitable medicine acceptable carrier, described medicine acceptable carrier is selected from: mannitol, sorbitol, sodium pyrosulfite, sodium sulfite, sodium thiosulfate, cysteine hydrochloride, TGA, methionine, vitamin C, the EDTA disodium, EDTA calcium sodium, the alkali-metal carbonate of monovalence, acetate, phosphate or its aqueous solution, hydrochloric acid, acetic acid, sulphuric acid, phosphoric acid, aminoacid, sodium chloride, potassium chloride, sodium lactate, xylitol, maltose, glucose, fructose, dextran, glycine, starch, sucrose, lactose, mannitol, silicon derivative, cellulose and derivant thereof, alginate, gelatin, polyvinylpyrrolidone, glycerol, soil temperature 80, agar, calcium carbonate, calcium bicarbonate, surfactant, Polyethylene Glycol, cyclodextrin, beta-schardinger dextrin-, the phospholipid material, Kaolin, Pulvis Talci, micropowder silica gel, magnesium carbonate, calcium stearate, magnesium stearate etc.
Preparation of the present invention is determined usage and dosage according to patient's situation in use, but obeys 1-4 time every day, each 1-20 agent, as: 1-20 grain or sheet.
Another object of the present invention is to provide a kind of preparation method of Chinese medicine preparation-capsule preparations of the present invention.Preferred manufacturing procedure is as follows: active substance of the present invention, and spray drying selects for use micropowder silica gel+dextrin to make fluidizer, magnesium carbonate is made diluent, granulates, and granulate adds adjuvant again, and the capsule method for making promptly can be made into capsule product of the present invention routinely.
Find when the present invention makes capsule that medicated powder is extractum spray drying gained in the capsule, during the fill capsule, usually occur the medicated powder flowability relatively poor, easily draw problems such as wet, method of double differences instability.It is done further research back finds the following aspects controlled and can overcome this problem: 1, adding micropowder silica gel in this preparation can increase the medicated powder flowability.2, add magnesium carbonate in this preparation and keep the cream dried bean noodles dry, if magnesium carbonate is excessive, then saturation is excessive, and the formation speed of nucleus and crystalline coarsening rate are also accelerated, and easily form crystallization.
When the present invention makes capsule, how to select for use proper supplementary material to make the flowability of capsule of the present invention and the weight differential can be up to specification, particularly can increase mobility of particle, and don't influence the maximum difficult point that its weight differential is this preparation.Below be selection experimental result to adjuvant:
| Fluidizer | Diluent | The result | |||
| Mobile | Weight differential | Moisture (%) | Disintegrate (min) | ||
| 3% modified starch | 10% microcrystalline Cellulose | Difference | Defective | 3.5 | 14 |
| 3% modified starch | 0.5% magnesium carbonate | Good | Qualified | 3.6 | 11 |
| 3% crospolyvinylpyrrolidone | 10% microcrystalline Cellulose | Difference | Defective | 7.0 | 15 |
| 3% crospolyvinylpyrrolidone | 0.5% magnesium carbonate | Better | Qualified | 5.8 | 13 |
| 3% crosslinked carboxymethylstach sodium | 10% microcrystalline Cellulose | Good | Defective | 5.6 | 16 |
| 3% crosslinked carboxymethylstach sodium | 0.5% magnesium carbonate | Better | Qualified | 4.8 | 11 |
| 3% micropowder silica gel+dextrin (4: 1) | 0.5% magnesium carbonate | Better | Qualified | 3.1 | 10 |
According to above experimental result, above fluidizer and diluent all can reach the prescription of capsule, after taking all factors into consideration, select for use micropowder silica gel+dextrin to make fluidizer, magnesium carbonate is made diluent, existing the supplementary product consumption of selecting for use are selected:
1, sees the following form with the factor level table
| Factor | Level | ||
| 1 | 2 | ||
| A | Micropowder silica gel+dextrin | 1％ | 4％ |
| B | A factor proportioning | 4∶1 | 1∶1 |
| C | Magnesium carbonate | 1％ | 0.75％ |
2, orthogonal experiment design table and result
| The experiment number | 1 A | 2 B | 3 A×B | 4 C | 5 | 6 | 7 | The result | Scoring |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | Mobile poor, the method for double differences is defective | 66.75 |
| 2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | Good fluidity, the method for double differences is qualified | 93.34 |
| 3 | 1 | 2 | 2 | 1 | 1 | 2 | 2 | Mobile poor, the method for double differences is qualified | 86.64 |
| 4 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | Good fluidity, the method for double differences is defective | 80.82 |
| 5 | 2 | 1 | 2 | 1 | 2 | 1 | 2 | Better mobile; The method of double differences is qualified | 84.27 |
| 6 | 2 | 1 | 2 | 2 | 1 | 2 | 1 | Better mobile; The method of double differences is qualified | 96.45 |
| 7 | 2 | 2 | 1 | 1 | 2 | 2 | 1 | Good fluidity; The method of double differences is defective | 83.38 |
| 8 | 2 | 2 | 1 | 2 | 1 | 1 | 2 | Good fluidity; The method of double differences is qualified | 82.05 |
Find out to have only C factor and A * B reciprocal action influence bigger from table.At C
2Situation under, B is arranged
1A
2And B
1A
1Best under two kinds of combined state.Consider the B factor affecting than the A factor affecting more greatly, and select B among the B
1For good, so select A
2B
1The final decision optimum formula is A like this
2B
1C
2, promptly accounting for the powder silica gel of total amount 4% and dextrin by the composite auxiliary material of forming at 4: 1, magnesium carbonate is 0.75%.
Study on extraction of the present invention:
One, Study on extraction
With catalpol content, yield of extract as index.The factor level table is as follows:
1, the factor level table sees the following form:
| Level | Factor | |||||||
| A | B | C | D | |||||
| Number of times (inferior) | Solvent (doubly) | Decocting time (h) | The concentrated solution relative density | Concentration of alcohol (%) | Pulverizing medicinal materials degree (order) | |||
| For the first time | For the second time | For the first time | For the second time | |||||
| 1 | 1 | 6 | 3 | 1.05 | 1.10 | 40 | 75 | The cutting of rattan turf class, the stripping and slicing of stem class |
| 2 | 2 | 8 | 2、2 | 1.10 | 1.15 | 60 | 95 | 60 |
| 3 | 3 | 10 | 2、1、0.5 | 1.15 | 1.20 | 55 | 85 | Do not pulverize |
2, orthogonal experiment design table and the results are shown in following table:
| Row number the experiment number | A | B | C | D | Yield of extract (%) | Catalpol content (mg/g) | Scoring |
| 1 | 1 | 1 | 1 | 1 | 19.55 | 0.9763 | 68.5 |
| 2 | 1 | 2 | 2 | 2 | 18.93 | 0.8963 | 63.7 |
| 3 | 1 | 3 | 3 | 3 | 19.44 | 0.8422 | 65.5 |
| 4 | 2 | 1 | 2 | 3 | 18.71 | 0.9854 | 60.1 |
| 5 | 2 | 2 | 3 | 1 | 27.64 | 1.3210 | 84.2 |
| 6 | 2 | 3 | 1 | 2 | 15.15 | 1.0154 | 44.6 |
| 7 | 3 | 1 | 3 | 2 | 20.32 | 1.1355 | 76.5 |
| 8 | 3 | 2 | 1 | 3 | 17.71 | 0.9554 | 58.5 |
| 9 | 3 | 3 | 2 | 1 | 19.28 | 0.8924 | 65.4 |
Above result optimised process as can be seen is A
2B
2C
3D
1, i.e. the seven flavor medicine material section of being ground in bulk adds the water of 8 times of amounts, decocts twice, each 2 hours.But be ground into comparatively difficulty of 60 orders filtration at the big Chinese crude drug of producing, and the influence of D factor is not remarkable, adopts optimised process A
2B
2C
3D
1, i.e. Caulis Polygoni Multiflori, Caulis Spatholobi, Herba Agrimoniae and Cortex Albiziae cutting, Radix Rehmanniae Preparata, Radix Rehmanniae and Herba Ecliptae stripping and slicing, the water that adds 8 times of amounts decocts twice, each 2 hours, twice spissated relative density is followed successively by the used concentration of alcohol of 1.10 and 1.15, twice alcohol extractions and is followed successively by 55% and 85%.
Below by pharmacodynamics test data declaration beneficial effect of the present invention:
The pharmacodynamic study of preparation for treating insomnia effect of the present invention:
Capsule of the present invention, the Chinese patent medicine by extracts such as Chinese medicine Radix Rehmanniae Preparata fleece-flower root rattan are formed has nourishing YIN and benefiting blood, and the effect of mind tranquilizing and the heart calming is mainly used in and is used for deficiency of YIN insufficiency of blood, dizzy cardiopalmus, diseases such as insomnia forgetfulness.For further its clinical efficacy and safety of proof to having a sleepless night, we are diagnosed as insomnia from JIUYUE, 2003～December to 100 examples, Chinese medical discrimination is that the insomnia patients of deficiency of YIN insufficiency of blood type and type of hyperactivity of fire caused by deficiency of YIN has carried out capsule clinical efficacy of the present invention and safety is observed, and has obtained curative effect preferably.
1 data and method
1.1 clinical data 100 routine insomnia patientses are the attached outpatient of institute of Guiyang College of Traditional Chinese Medicine, male 25 examples, and women 75 examples, men and women's ratio is 1: 3.18～65 years old age.51 ± 10.54 years old mean age, average course of disease 5.08 ± 3.28.Chinese medical discrimination is type of hyperactivity of fire caused by deficiency of YIN 38 examples; Deficiency of YIN insufficiency of blood type 42 examples; Type of deficiency of both the heart and spleen 20 examples.
1.2 diagnostic criteria (1) has the insomnia classical symptom, difficulty falling asleep, and awakening is often slept and shakiness, or can not sleep after waking up again, and wake up too early morning.Can not fall asleep night, daytime lethargic and drowsy state, 5h does not have enough sleep.(2) meet the Chinese medical discrimination typing, deficiency of YIN insufficiency of blood type, type of hyperactivity of fire caused by deficiency of YIN, type of deficiency of both the heart and spleen.(3) have a sleepless night more than lasting January.
1.3 observational technique capsule of the present invention: every day 1 time, 1～2, administered before bed time usefulness, 1 week was 1 course of treatment, period in a medicine is prohibited other medicines of sleeping peacefully of clothes.
1.4 observation index (1) sleep quality (sleep time, awakening number of times, time for falling asleep, the back mental status of waking up, sleep state) standards of grading are with reference to national traditional Chinese medical science medical diagnosis on disease standard.(2) tcm syndrome (dizziness headache, the Mental fatigue soreness of waist, tinnitus, cardiopalmus, agitation) standards of grading represent that with the sxemiquantitative integration method asymptomatic is 0 minute, slightly is 1 minute, and moderate is 2 minutes, and severe is 3 minutes.(3) safety indexes (general physical examination, hematuria routine, EKG, SGPT, BUN, Cr) before and after the treatment each 1 time.
1.5 curative effect determinate standard (1) sleep criterion: 1. clinical recovery: sleep recovers normal, or nighttime sleep time＞6h, and sleep is dull, and the back of waking up is energetic.2. produce effects: increase the length of one's sleep more than the 3h, the back spirit of waking up is clearly better.3. effective: increase not enough 3h the length of one's sleep, the back spirit of waking up take a favorable turn.4. invalid: sleep does not have obviously improvement, or does not increase the weight of the person on the contrary.(2) tcm syndrome criterion: 1. produce effects: treatment back symptom integral descends＞2/3.2. effective: treatment back symptom integral descends＞1/3.3. invalid: treatment back symptom integral descends＜1/3.
2 the results are shown in Table 1,2.
Table 1 insomnia observation of curative effect
| The Chinese medical discrimination typing | 1. clinical recovery | 2. produce effects | 3. effective | 4. invalid |
| Deficiency of YIN insufficiency of blood type | 29 | 8 | 5 | 0 |
| Type of hyperactivity of fire caused by deficiency of YIN | 28 | 4 | 6 | 0 |
| Type of deficiency of both the heart and spleen | 15 | 3 | 2 | 0 |
Table 2 tcm syndrome observation of curative effect
| Tcm syndrome | Produce effects | Effectively | Invalid |
| Deficiency of YIN insufficiency of blood type | 29 | 13 | 0 |
| Type of hyperactivity of fire caused by deficiency of YIN | 26 | 11 | 1 |
| Type of deficiency of both the heart and spleen | 13 | 6 | 1 |
Untoward reaction: (1) clinical symptoms: after having 2 routine patients to take capsule of the present invention among the 100 routine patients, feel feeling of fullness in the head obvious, drug withdrawal after transference cure when waking up the 2nd day morning.(2) lab testing: have no adverse reaction.
3 medical records for example
The patient, woman, 46 years old.This patient suffered from chronic hepatitis nearly 10 years, and it is poor sleep that fatigue is arranged over 2 years slightly, and only sleep about 4h every day.Easily awake dreaminess feels dizzy weak daytime, the soreness of waist, tinnitus, cardiopalmus, dysphoria, the tender white and thin fur of tongue, thready and rolling pulse.On October 4th, 2003 went to a doctor, and was diagnosed as insomnia, deficiency of YIN insufficiency of blood type.Use capsule of the present invention, sleep preceding 1.Take sleep in back 2 days and promptly recover normal, can sleep about 7h every day, and very fast sleeping, and it is intoxicated to sleep, and next day, subjective symptoms was also obviously improved.
We show through 100 routine clinical case observed results: capsule of the present invention has the hypnotic effect of calming the nerves preferably, and especially to early stage light, medium-sized patient, effect is better, and is longer to those insomnia courses of disease, the patient that the state of an illness is heavier, and effect is relatively poor relatively.Apparent in view to some spirituality doing well,improvings, as dizziness headache cardio palmus shape, and to the soreness of waist, symptoms such as tinnitus do not have obvious curative effects.Capsule of the present invention reaches 98% through the clinical verification total effective rate, and does not have obvious toxic-side effects, is a kind of safe and reliable nourishing blood to tranquillize the mind good medicine.
Compared with prior art: preparation provided by the invention has the effect that nourishing YIN and benefiting blood is calmed the nerves, and insomnia, dizziness, cardiopalmus, disease such as forgetful are had definite curative effect.The preparations such as ball sheet of routine are made capsule, by water and Different concentrations of alcohol alternate treatment, promptly adopt decoction and alcohol sedimentation technique, keep iridoid glycoside, the dissociated anthraquinone glycoside, effective ingredient such as alkaloid have been removed gelatinized starch, phlegmatic temperament and saccharide overwhelming majority impurity, the quality and the clinical treatment effect that have improved preparation.
The specific embodiment:
Further specify the present invention by the following examples, but not as limitation of the present invention.
Embodiment 1:
Caulis Polygoni Multiflori 100g, Caulis Spatholobi 100g, Radix Rehmanniae Preparata 100g, Radix Rehmanniae 100g, Cortex Albiziae 100g, Herba Ecliptae 140g, Herba Agrimoniae 160g, powder silica gel and dextrin are by the composite auxiliary material 33.60g of 4: 1 compositions, magnesium carbonate 6.30g
Method for making: above seven flavors, Caulis Polygoni Multiflori, Caulis Spatholobi, Herba Agrimoniae and Cortex Albiziae cutting, Radix Rehmanniae Preparata, Radix Rehmanniae and Herba Ecliptae stripping and slicing, add 800ml water, soak after 1 hour and decoct each 2h, collecting decoction 2 times, filter, add 55% ethanol during filtrate concentrate under reduced pressure at low temperature to 50 ℃ during 1.05,40 ℃ of relative densities, stir, make medicinal liquid contain the alcohol amount and reach 55%, under 5 ℃, left standstill 8 hours.Get supernatant, add 85% ethanol again, stir, make medicinal liquid contain the alcohol amount and reach 85%, under 5 ℃, left standstill the siphon supernatant 10 hours, lower floor's magma is sucking filtration slowly again, merging filtrate, and concentrate under reduced pressure at low temperature to relative density is the clear paste of 1.10 (50 ℃), spray-drying process, granulate adds micropowder silica gel and the dextrin composite auxiliary material by 4: 1 compositions, magnesium carbonate, mix homogeneously promptly can be made into capsule by the capsule method for making.
Embodiment 2:
Caulis Polygoni Multiflori 30g, Caulis Spatholobi 30g, Radix Rehmanniae Preparata 30g, Radix Rehmanniae 30g, Cortex Albiziae 30g, Herba Ecliptae 30g, Herba Agrimoniae 120g, powder silica gel and dextrin are by composite auxiliary material 11.34g, the magnesium carbonate 2.13g of 4: 1 compositions
Method for making: above seven flavors, Caulis Polygoni Multiflori, Caulis Spatholobi, Herba Agrimoniae and Cortex Albiziae cutting, Radix Rehmanniae Preparata, Radix Rehmanniae and Herba Ecliptae stripping and slicing, add 800ml water, soak after 1 hour and decoct each 2h, collecting decoction 2 times, filter, add 55% ethanol during filtrate concentrate under reduced pressure at low temperature to 50 ℃ during 1.05,40 ℃ of relative densities, stir, make medicinal liquid contain the alcohol amount and reach 55%, under 5 ℃, left standstill 8 hours.Get supernatant, add 85% ethanol again, stir, make medicinal liquid contain the alcohol amount and reach 85%, under 5 ℃, left standstill the siphon supernatant 10 hours, lower floor's magma is sucking filtration slowly again, merging filtrate, and concentrate under reduced pressure at low temperature to relative density is the clear paste of 1.15 (50 ℃), spray-drying process, granulate adds micropowder silica gel and the dextrin composite auxiliary material by 4: 1 compositions, magnesium carbonate, mixing promptly can be made into capsule by the capsule method for making.
Embodiment 3:
Caulis Polygoni Multiflori 180g, Caulis Spatholobi 180g, Radix Rehmanniae Preparata 180g, Radix Rehmanniae 180g, Cortex Albiziae 180g, Herba Ecliptae 180g, Herba Agrimoniae 200g, powder silica gel and dextrin are by composite auxiliary material 76.4g, the magnesium carbonate 14.33g of 4: 1 compositions
Method for making: above seven flavors, Caulis Polygoni Multiflori, Caulis Spatholobi, Herba Agrimoniae and Cortex Albiziae cutting, Radix Rehmanniae Preparata, Radix Rehmanniae and Herba Ecliptae stripping and slicing, add 800ml water, soak after 1 hour and decoct each 2h, collecting decoction 2 times, filter, add 55% ethanol during filtrate concentrate under reduced pressure at low temperature to 50 ℃ during 1.05,40 ℃ of relative densities, stir, make medicinal liquid contain the alcohol amount and reach 55%, under 5 ℃, left standstill 8 hours.Get supernatant, add 85% ethanol again, stir, make medicinal liquid contain the alcohol amount and reach 85%, under 5 ℃, left standstill the siphon supernatant 10 hours, lower floor's magma is sucking filtration slowly again, merging filtrate, and concentrate under reduced pressure at low temperature to relative density is the clear paste of 1.15 (50 ℃), spray-drying process, granulate adds micropowder silica gel and the dextrin composite auxiliary material by 4: 1 compositions, magnesium carbonate, mixing promptly can be made into capsule by the capsule method for making.
Embodiment 4:
Caulis Polygoni Multiflori 30g, Caulis Spatholobi 180g, Radix Rehmanniae Preparata 30g, Radix Rehmanniae 180g, Cortex Albiziae 30g, Herba Ecliptae 180g, Herba Agrimoniae 120g, powder silica gel and dextrin are by composite auxiliary material 31.50g, the magnesium carbonate 5.90g of 4: 1 compositions
Method for making: above seven flavors, Caulis Polygoni Multiflori, Caulis Spatholobi, Herba Agrimoniae and Cortex Albiziae cutting, Radix Rehmanniae Preparata, Radix Rehmanniae and Herba Ecliptae stripping and slicing, add 800ml water, soak after 1 hour and decoct each 2h, collecting decoction 2 times, filter, add 55% ethanol during filtrate concentrate under reduced pressure at low temperature to 50 ℃ during 1.05,40 ℃ of relative densities, stir, make medicinal liquid contain the alcohol amount and reach 55%, under 5 ℃, left standstill 8 hours.Get supernatant, add 85% ethanol again, stir, make medicinal liquid contain the alcohol amount and reach 85%, under 5 ℃, left standstill the siphon supernatant 10 hours, lower floor's magma is sucking filtration slowly again, merging filtrate, and concentrate under reduced pressure at low temperature to relative density is the clear paste of 1.15 (50 ℃), spray-drying process, granulate adds micropowder silica gel and the dextrin composite auxiliary material by 4: 1 compositions, magnesium carbonate, mixing promptly can be made into capsule by the capsule method for making.
Embodiment 5:
Caulis Polygoni Multiflori 180g, Caulis Spatholobi 30g, Radix Rehmanniae Preparata 180g, Radix Rehmanniae 30g, Cortex Albiziae 180g, Herba Ecliptae 30g, Herba Agrimoniae 200g, powder silica gel and dextrin are by composite auxiliary material 34.86g, the magnesium carbonate 6.54g of 4: 1 compositions
Method for making: above seven flavors, Caulis Polygoni Multiflori, Caulis Spatholobi, Herba Agrimoniae and Cortex Albiziae cutting, Radix Rehmanniae Preparata, Radix Rehmanniae and Herba Ecliptae stripping and slicing, add 800ml water, soak after 1 hour and decoct each 2h, collecting decoction 2 times, filter, add 55% ethanol during filtrate concentrate under reduced pressure at low temperature to 50 ℃ during 1.05,40 ℃ of relative densities, stir, make medicinal liquid contain the alcohol amount and reach 55%, under 5 ℃, left standstill 8 hours.Get supernatant, add 85% ethanol again, stir, make medicinal liquid contain the alcohol amount and reach 85%, under 5 ℃, left standstill the siphon supernatant 10 hours, lower floor's magma is sucking filtration slowly again, merging filtrate, and concentrate under reduced pressure at low temperature to relative density is the clear paste of 1.15 (50 ℃), spray-drying process, granulate adds micropowder silica gel and the dextrin composite auxiliary material by 4: 1 compositions, magnesium carbonate, mixing promptly can be made into capsule by the capsule method for making.
Embodiment 6:
Caulis Polygoni Multiflori 180g, Caulis Spatholobi 180g, Radix Rehmanniae Preparata 180g, Radix Rehmanniae 30g, Cortex Albiziae 30g, Herba Ecliptae 30g, Herba Agrimoniae 160g, powder silica gel and dextrin are by composite auxiliary material 33.18g, the magnesium carbonate 6.22g of 4: 1 compositions
Method for making: above seven flavors, Caulis Polygoni Multiflori, Caulis Spatholobi, Herba Agrimoniae and Cortex Albiziae cutting, Radix Rehmanniae Preparata, Radix Rehmanniae and Herba Ecliptae stripping and slicing, add 800ml water, soak after 1 hour and decoct each 2h, collecting decoction 2 times, filter, add 55% ethanol during filtrate concentrate under reduced pressure at low temperature to 50 ℃ during 1.05,40 ℃ of relative densities, stir, make medicinal liquid contain the alcohol amount and reach 55%, under 5 ℃, left standstill 8 hours.Get supernatant, add 85% ethanol again, stir, make medicinal liquid contain the alcohol amount and reach 85%, under 5 ℃, left standstill the siphon supernatant 10 hours, lower floor's magma is sucking filtration slowly again, merging filtrate, and concentrate under reduced pressure at low temperature to relative density is the clear paste of 1.15 (50 ℃), spray-drying process, granulate adds micropowder silica gel and the dextrin composite auxiliary material by 4: 1 compositions, magnesium carbonate, mixing promptly can be made into capsule by the capsule method for making.
Embodiment 7:
Caulis Polygoni Multiflori 30g, Caulis Spatholobi 30g, Radix Rehmanniae Preparata 30g, Radix Rehmanniae 30g, Cortex Albiziae 180g, Herba Ecliptae 180g, Herba Agrimoniae 200g, powder silica gel and dextrin are by composite auxiliary material 28.56g, the magnesium carbonate 5.35g of 4: 1 compositions
Method for making: above seven flavors, Caulis Polygoni Multiflori, Caulis Spatholobi, Herba Agrimoniae and Cortex Albiziae cutting, Radix Rehmanniae Preparata, Radix Rehmanniae and Herba Ecliptae stripping and slicing, add 800ml water, soak after 1 hour and decoct each 2h, collecting decoction 2 times, filter, add 55% ethanol during filtrate concentrate under reduced pressure at low temperature to 50 ℃ during 1.05,40 ℃ of relative densities, stir, make medicinal liquid contain the alcohol amount and reach 55%, under 5 ℃, left standstill 8 hours.Get supernatant, add 85% ethanol again, stir, make medicinal liquid contain the alcohol amount and reach 85%, under 5 ℃, left standstill the siphon supernatant 10 hours, lower floor's magma is sucking filtration slowly again, merging filtrate, and concentrate under reduced pressure at low temperature to relative density is the clear paste of 1.15 (50 ℃), spray-drying process, granulate adds micropowder silica gel and the dextrin composite auxiliary material by 4: 1 compositions, magnesium carbonate, mixing promptly can be made into capsule by the capsule method for making.
Embodiment 8:
Caulis Polygoni Multiflori 30g, Caulis Spatholobi 30g, Radix Rehmanniae Preparata 30g, Radix Rehmanniae 30g, Cortex Albiziae 30g, Herba Ecliptae 30g, Herba Agrimoniae 120g, powder silica gel and dextrin are by composite auxiliary material 11.34g, the magnesium carbonate 2.13g of 4: 1 compositions
Method for making: above seven flavors, Caulis Polygoni Multiflori, Caulis Spatholobi, Herba Agrimoniae and Cortex Albiziae cutting, Radix Rehmanniae Preparata, Radix Rehmanniae and Herba Ecliptae stripping and slicing, add 600ml water, soak after 0.5 hour and decoct each 2h, collecting decoction 1 time, filter, add 50% ethanol during filtrate concentrate under reduced pressure at low temperature to 50 ℃ during 1.05,40 ℃ of relative densities, stir, make medicinal liquid contain the alcohol amount and reach 50%, under 5 ℃, left standstill 6 hours.Get supernatant, add 70% ethanol again, stir, make medicinal liquid contain the alcohol amount and reach 70%, under 5 ℃, left standstill the siphon supernatant 8 hours, lower floor's magma is sucking filtration slowly again, merging filtrate, and concentrate under reduced pressure at low temperature to relative density is the clear paste of 1.10 (50 ℃), spray-drying process, granulate adds micropowder silica gel and the dextrin composite auxiliary material by 4: 1 compositions, magnesium carbonate, mixing promptly can be made into capsule by the capsule method for making.
Embodiment 9:
Caulis Polygoni Multiflori 180g, Caulis Spatholobi 180g, Radix Rehmanniae Preparata 180g, Radix Rehmanniae 180g, Cortex Albiziae 180g, Herba Ecliptae 180g, Herba Agrimoniae 200g, powder silica gel and dextrin are by composite auxiliary material 76.4g, the magnesium carbonate 14.33g of 4: 1 compositions
Method for making: above seven flavors, Caulis Polygoni Multiflori, Caulis Spatholobi, Herba Agrimoniae and Cortex Albiziae cutting, Radix Rehmanniae Preparata, Radix Rehmanniae and Herba Ecliptae stripping and slicing, add 1000ml water, soak after 5 hours and decoct each 2h, collecting decoction 3 times, filter, add 60% ethanol during filtrate concentrate under reduced pressure at low temperature to 50 ℃ during 1.15,40 ℃ of relative densities, stir, make medicinal liquid contain the alcohol amount and reach 60%, under 10 ℃, left standstill 10 hours.Get supernatant, add 90% ethanol again, stir, make medicinal liquid contain the alcohol amount and reach 90%, under 10 ℃, left standstill the siphon supernatant 12 hours, lower floor's magma is sucking filtration slowly again, merging filtrate, and concentrate under reduced pressure at low temperature to relative density is the clear paste of 1.20 (50 ℃), spray-drying process, granulate adds micropowder silica gel and the dextrin composite auxiliary material by 4: 1 compositions, magnesium carbonate, mixing promptly can be made into capsule by the capsule method for making.
Claims (10)
1, a kind of nourishing blood to tranquillize the mind Chinese medicine preparation, make by following Chinese medicinal raw materials:
Caulis Polygoni Multiflori 30-180 part, Caulis Spatholobi 30-180 part, Radix Rehmanniae Preparata 30-180 part, Radix Rehmanniae 30-180 part, Cortex Albiziae 30-180 part, Herba Ecliptae 30-180 part, Herba Agrimoniae 120-200 part.
2, the Chinese medicine preparation of claim 1, make by following Chinese medicinal raw materials:
100 parts of Caulis Polygoni Multiflori, 100 parts of Caulis Spatholobis, 100 parts of Radix Rehmanniae Preparata, 100 parts of Radix Rehmanniae, 100 parts of Cortex Albiziaes, 140 parts of Herba Ecliptaes, 160 parts of Herba Agrimoniaes.
3, the Chinese medicine preparation of claim 1 is by raw material of Chinese medicine being processed through extraction or other modes, being made pharmaceutically active substance, is raw material with this active substance, adds the medicine acceptable carrier in case of necessity, makes according to the routine techniques of galenic pharmacy.
4, the Chinese medicine preparation of claim 3, wherein extracting and making pharmaceutically active substance is to adopt decoction and alcohol sedimentation technique.
5, the Chinese medicine preparation of claim 4, wherein said decoction and alcohol sedimentation technique process following steps: medical material is cut into chunks, and decocts with water, and collecting decoction filters concentrate under reduced pressure at low temperature; Add Different concentrations of alcohol at twice, fully stir, leave standstill, divide and get supernatant, sucking filtration merges, and concentrate under reduced pressure at low temperature gets clear paste, promptly.
6, the Chinese medicine preparation of claim 5, wherein said decoction and alcohol sedimentation technique process following steps: pulverizing medicinal materials becomes section or piece, add 6-10 times of water, soak after 0.5-5 hour and decoct 1-3 time, each 2 hours, collecting decoction filters, and gets the filtrate concentrate under reduced pressure at low temperature and to relative density be 1.05～1.15 clear paste; Add the ethanol of 50-60% in the time of 40 ℃, stir, make medicinal liquid contain the alcohol amount and reach 50-60%, under 5-10 ℃, left standstill 6-8 hour.Divide and get supernatant, add the ethanol of 75-90% again, stir, make medicinal liquid contain the alcohol amount and reach 75-90%, left standstill under 5-10 ℃ 8-12 hour, siphon supernatant, lower floor's magma be sucking filtration slowly again, merging filtrate, concentrate under reduced pressure at low temperature to relative density are 1.10～1.20 clear paste, promptly.
7, the Chinese medicine preparation of claim 1 is tablet, capsule, oral liquid, syrup, granule, pill, powder, unguentum, sublimed preparation, injection, suppository, cream, spray, drop pill, patch, slow releasing preparation or controlled release preparation.
8, the Chinese medicine preparation of claim 7 is capsules.
9, the preparation method of the Chinese medicine preparation of claim 1 is characterized in that, is by the raw material of Chinese medicine process being extracted, being made pharmaceutically active substance, is raw material with this active substance, adds the medicine acceptable carrier, makes according to the routine techniques of galenic pharmacy; Decoction and alcohol sedimentation technique is adopted in wherein said extraction.
10, the preparation method of claim 9, it is characterized in that, wherein said decoction and alcohol sedimentation technique process following steps: pulverizing medicinal materials becomes section or piece, add 6-10 times of water, soak after 0.5-5 hour and to decoct 1-3 time, each 2 hours, collecting decoction, filter, get the filtrate concentrate under reduced pressure at low temperature and be 1.05～1.15 clear paste to relative density; Add the ethanol of 50-60% in the time of 40 ℃, stir, make medicinal liquid contain the alcohol amount and reach 50-60%, under 5-10 ℃, left standstill 6-8 hour.Divide and get supernatant, add the ethanol of 75-90% again, stir, make medicinal liquid contain the alcohol amount and reach 75-90%, left standstill under 5-10 ℃ 8-12 hour, siphon supernatant, lower floor's magma be sucking filtration slowly again, merging filtrate, concentrate under reduced pressure at low temperature to relative density are 1.10～1.20 clear paste, promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100031814A CN100353968C (en) | 2005-08-25 | 2005-08-25 | Chinese medicine preparation for nourishing blood and tranquilizing mind and its preparation process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100031814A CN100353968C (en) | 2005-08-25 | 2005-08-25 | Chinese medicine preparation for nourishing blood and tranquilizing mind and its preparation process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1733081A true CN1733081A (en) | 2006-02-15 |
| CN100353968C CN100353968C (en) | 2007-12-12 |
Family
ID=36075836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100031814A Expired - Fee Related CN100353968C (en) | 2005-08-25 | 2005-08-25 | Chinese medicine preparation for nourishing blood and tranquilizing mind and its preparation process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100353968C (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104306541A (en) * | 2014-11-26 | 2015-01-28 | 黑龙江省智诚医药科技有限公司 | A kind of traditional Chinese medicine dispersible tablet for nourishing blood and calming nerves and preparation method thereof |
| CN104324080A (en) * | 2014-11-18 | 2015-02-04 | 郝建友 | Injection for treating upper respiratory tract infection and preparation method thereof |
| CN105943696A (en) * | 2016-06-02 | 2016-09-21 | 瑞安市智造科技有限公司 | External antianxiety traditional Chinese medicine composition and preparing method thereof |
| CN107320564A (en) * | 2017-07-03 | 2017-11-07 | 广西大海阳光药业有限公司 | A kind of Chinese medicine preparation for treating vertigo and palpitation, insomnia forgetfulness and preparation method thereof |
| CN107362272A (en) * | 2017-08-31 | 2017-11-21 | 江西金顶药业有限公司 | A kind of Yangxue Anshen Syrup |
| CN107714849A (en) * | 2017-11-16 | 2018-02-23 | 广西博白县华春福家庭农场 | A kind of Chinese medicine composition for treating myocardial ischemia and preparation method thereof |
| CN119909022A (en) * | 2025-03-17 | 2025-05-02 | 上海国创医药股份有限公司 | A kind of blood-nourishing and tranquilizing granules and preparation method thereof |
-
2005
- 2005-08-25 CN CNB2005100031814A patent/CN100353968C/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104324080A (en) * | 2014-11-18 | 2015-02-04 | 郝建友 | Injection for treating upper respiratory tract infection and preparation method thereof |
| CN104324080B (en) * | 2014-11-18 | 2016-11-23 | 王述明 | Injection for treating upper respiratory tract infection and preparation method thereof |
| CN104306541A (en) * | 2014-11-26 | 2015-01-28 | 黑龙江省智诚医药科技有限公司 | A kind of traditional Chinese medicine dispersible tablet for nourishing blood and calming nerves and preparation method thereof |
| CN105943696A (en) * | 2016-06-02 | 2016-09-21 | 瑞安市智造科技有限公司 | External antianxiety traditional Chinese medicine composition and preparing method thereof |
| CN107320564A (en) * | 2017-07-03 | 2017-11-07 | 广西大海阳光药业有限公司 | A kind of Chinese medicine preparation for treating vertigo and palpitation, insomnia forgetfulness and preparation method thereof |
| CN107362272A (en) * | 2017-08-31 | 2017-11-21 | 江西金顶药业有限公司 | A kind of Yangxue Anshen Syrup |
| CN107714849A (en) * | 2017-11-16 | 2018-02-23 | 广西博白县华春福家庭农场 | A kind of Chinese medicine composition for treating myocardial ischemia and preparation method thereof |
| CN119909022A (en) * | 2025-03-17 | 2025-05-02 | 上海国创医药股份有限公司 | A kind of blood-nourishing and tranquilizing granules and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100353968C (en) | 2007-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1857618A (en) | Chinese medicine preparation for reducing sugar | |
| CN103006838B (en) | Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases | |
| CN103006769B (en) | Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN100353968C (en) | Chinese medicine preparation for nourishing blood and tranquilizing mind and its preparation process | |
| CN102370901A (en) | Pharmaceutical composition for treating nephrosis and preparing process thereof | |
| CN103028109B (en) | Traditional Chinese medicine agent for treating Alzheimer disease | |
| CN1742879A (en) | Chinese medicine for reducing blood sugar and preparation thereof | |
| CN1775261A (en) | Mingmu-Dihuang preparation and new preparing method | |
| CN102988478B (en) | Traditional Chinese medicine combination for treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN1679706A (en) | Medicinal preparation containing notoginseng and rhodiola root for cardio-cerebral blood vessel diseases and its preparing method | |
| CN1246016C (en) | Compound formulation of traditional Chinese medicine for climacteric syndrome and preparation method | |
| CN100509009C (en) | A traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and ischemic stroke and its preparation method | |
| CN1679697A (en) | Chinese medicine preparation for treating cardio vascular disease and containing notoginseng, pericarpium trichosanthis and leech, for treating cardio-cerebral blood vessel diseases and its preparing | |
| CN101574454B (en) | Rehabilitation reconstruction traditional Chinese medicine | |
| CN1297254C (en) | Drop pills containing bear gall and tendril-leaved fritillary bulb and preparation method thereof | |
| CN1785414A (en) | Compound Chinese medicine for anticancer and its preparation method | |
| CN101797348B (en) | Traditional Chinese medicine for treating proliferative vitreoretinopathy | |
| CN1679701A (en) | Medicinal preparation containing notoginseng and saflower for treating cardio-cerebral blood diseases and its preparing method | |
| CN1686484A (en) | Bastard feverfew throat clearing drip pill and its preparation method | |
| CN1903248A (en) | Medicine for treating female climacterium syndrome and its prepn. method | |
| CN1679700A (en) | Medicinal preparation containing notoginseng and pueraria root for treating cardio-cerebral blood vessel diseases and its preparing method | |
| CN1586517A (en) | Chinese medicine preparation for treating gynecologic inflammation | |
| CN1634145A (en) | 'Xingnaojing' dripping pills for treating cephalitis and hepatic coma and preparation process thereof | |
| CN1301095C (en) | 'Yinchai' drop pills for treating cold, fever and cough and preparation method | |
| CN1698802A (en) | Chinese medicinal compound preparation for treating vascular diseases and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071212 Termination date: 20090925 |